| 0 (0%) | 11-11 17:47 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.75  |
1-year : | 0.8 |
| Resists | First : | 0.64 |
Second : | 0.68 |
| Pivot price | 0.62 |
|||
| Supports | First : | 0.57 |
Second : | 0.47 |
| MAs | MA(5) : | 0.59 |
MA(20) : | 0.63 |
| MA(100) : | 0.73 |
MA(250) : | 0.79 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 3.3 |
D(3) : | 5.2 |
| RSI | RSI(14): 25.9 |
|||
| 52-week | High : | 1.25 | Low : | 0.55 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ ONTX ] has closed below the lower bollinger band by 4.4%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ ONTX ] is to continue within current trading range. Bollinger Bands are 38.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.6 - 0.61 | 0.61 - 0.61 |
| Low: | 0.56 - 0.57 | 0.57 - 0.57 |
| Close: | 0.57 - 0.58 | 0.58 - 0.58 |
Sat, 09 Mar 2024
We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully - Yahoo Finance
Fri, 21 Apr 2023
Penny Stocks To Buy Now? 5 With Big News Today - PennyStocks.com
Thu, 20 May 2021
Why Onconova Therapeutics (ONTX) Stock Is Up Sharply - Market Realist
Tue, 17 Dec 2013
Onconova Therapeutics Inc. (ONTX) Is Declining After Phase 3 Trial Discontinued - RTTNews
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 21 (M) |
| Held by Insiders | 2.084e+007 (%) |
| Held by Institutions | 0.7 (%) |
| Shares Short | 31 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -2.155e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -8 % |
| Return on Assets (ttm) | 928 % |
| Return on Equity (ttm) | -38.1 % |
| Qtrly Rev. Growth | 226000 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -62.45 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -17 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 1.12 |
| Dividend | 0 |
| Forward Dividend | 20700 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|